Jared Henderson - Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 39 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comprehensive Characterization and Validation of the Tumor Microenvironment in Patients with Relapsed/Refractory Large B-Cell Lymphoma Identifies Subgroups with Greatest Benefit from CD19 CAR T-Cell Therapy

Xubin Li, Kartik Singhal, Qing Deng, Dai Chihara,David A Russler-Germain, Usama Hussein,Jennifer Ann Foltz,Jared Henderson,Ashley Wilson, Evelyn Schmidt, Imran A. Nizamuddin, Tommy Dinh,

Bloodno. Supplement 1 (2024): 643-643

引用0浏览0引用

Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors in Vivo

Claudia Kettlun,Daniel Galvan, Jie Xu, Tania P Sainz Zuniga, Sebastian Juarez-Casillas, Daisy Y. Diaz Rohena,Vishal Sahu, Juan Andres Donoso, Arrate Zubero, Estela Rojas-Neira, David Blake,Jared Henderson,

Bloodno. Supplement 1 (2024): 4373-4373

引用0浏览0引用

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee,Gregory Ravizzini,Eslam Aboismail, Jenna Wixom,Jared Henderson,Luis E. Fayad, Sairah Ahmed, Ranjit Nair,Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki,

Bloodno. Supplement 1 (2024): 1674.3-1674.3

引用0浏览0引用

Radiation Therapy and Monocyte Activation in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy

Penny Q. Fang,Susan Y. Wu, Jillian R. Gunther, Alena Frank, Pavel Zemskiy,Aleksandr Zaitsev, Evgenii S Bolshakov, Anastasiya Terenteva,Krystle Nomie,Michelly Abreu,Karla Ow,Minifrida Santiago,

Bloodno. Supplement 1 (2024): 4377-4377

引用0浏览0引用

Inhibition of MALT1 and BCL2 Induces Synergistic Anti-Tumor Activity in Models of B Cell Lymphoma

Joshua P. Plotnik, Adam E. Richardson,Haopeng Yang,Estela Rojas,Velitchka Bontcheva, Colleen Dowell,Sydney Parsons,Ashley Wilson,Vida Ravanmehr,Christine Will,Paul Jung,Haizhong Zhu,

MOLECULAR CANCER THERAPEUTICSno. 7 (2024): 949-960

引用0浏览0WOS引用

A Phase I Investigator-Initiated Trial of Evorpacept (ALX148), Lenalidomide and Rituximab for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Paolo Strati,Lei Feng,Dai Chihara,Jason Westin,Sairah Ahmed,Luis Fayad,Jared Henderson, Jeffrey Davidson, Elizabeth McChesney,Loretta Nastoupil,Sattva Neelapu,Christopher Flowers

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

SMARCA4 is a Haploinsufficient B Cell Lymphoma Tumor Suppressor That Fine-Tunes Centrocyte Cell Fate Decisions

Qing Deng,Priya Lakra,Panhong Gou,Haopeng Yang,Cem Meydan,Matthew Teater,Christopher Chin,Wenchao Zhang, Tommy Dinh, Usama Hussein,Xubin Li,Estela Rojas,

CANCER CELLno. 4 (2024)

引用0浏览0WOS引用

Abstract CT037: A Phase I Investigator-Initiated Trial of Evorpacept (ALX148), Lenalidomide and Rituximab for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Paolo Strati,Lei Feng,Dai Chihara,Jason Westin,Sairah Ahmed,Luis Fayad,Jared Henderson, Jeffrey Davidson, Elizabeth McChesney,Loretta Nastoupil,Sattva Neelapu,Christopher Flowers

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Effect of Delayed Cell Infusion in Patients with Large B-cell Lymphoma Treated with Chimeric Antigen Receptor T-cell Therapy

Andrew P. Jallouk,Naishu Kui,Ryan Sun,Jason R. Westin,Raphael E. Steiner,Ranjit Nair,Loretta J. Nastoupil,Luis E. Fayad,Ajlan Al Zaki,Misha Hawkins,Sherry Adkins,Mansoor Noorani,

HAEMATOLOGICA（2024）

引用0浏览0WOS引用

Supplementary Figure 6 from Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma

Joshua P. Plotnik, Adam E. Richardson,Haopeng Yang,Estela Rojas,Velitchka Bontcheva, Colleen Dowell,Sydney Parsons,Ashley Wilson,Vida Ravanmehr,Christine Will,Paul Jung,Haizhong Zhu,

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn